Apexigen, Inc. Annual Operating Income (Loss) in USD from 2021 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Apexigen, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2022.
  • Apexigen, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$6.16M, a 24.4% increase year-over-year.
  • Apexigen, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$27.8M, a 39.4% increase year-over-year.
  • Apexigen, Inc. annual Operating Income (Loss) for 2022 was -$32.7M, a 12.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$32.7M -$3.73M -12.9% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-22
2021 -$29M Jan 1, 2021 Dec 31, 2021 10-K 2023-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.